Anika Therapeutics (ANIK) Amortizatization of Intangibles (2019)

Anika Therapeutics' (ANIK) quarterly Amortizatization of Intangibles came in at $294000.0 in Q2 2019, down 1.01% on a QoQ basis from $297000.0 in Q1 2019.

Anika Therapeutics (ANIK) Amortizatization of Intangibles (2019) Analysis & Trends

Anika Therapeutics (ANIK) has 1 years of Amortizatization of Intangibles data on file, last reported at $294000.0 in Q2 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn -
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn -
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn -
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 1.30 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -
10 Anika Therapeutics 203.64 Mn 136.85 Mn 19.00 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2019 294,000.00
Jun 30, 2019 294,000.00
Mar 31, 2019 297,000.00
Mar 31, 2019 297,000.00